Actively hiring
Machine Learning
Drug Discovery AI
As featured in
View 3 jobs
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$29.3M
2 rounds on record
Latest round
$25M
Series A · May 2025 · 17 mo ago
Team
51-200
employees, estimated range
Hiring now
5
open roles
Backers
3
Andreessen Horowitz, AlleyCorp
The money's age
Due for its next round
17 months since the last round · hiring slowed
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 13
Launched Inductive Bio launches Indy, an AI chemistry assistant, to double the capacity of every medicinal chemist · PRNewswire
May 11, 2025
Raised a round Series A $25M · led by Obvious Ventures · Pulse 2.0
Dec 19, 2023
Raised a round Venture round $4.3M · led by Andreessen Ho · Pulse 2.0
Dec 12, 2023
Launched Inductive Bio Emerges from Stealth, Unveiling an ML Platform to Accelerate Compound Optimization in Drug Discovery · PRNewswire
2021
Founded
Tractionpublic signals, read monthly
Web presence
top 3%
of 133.2M domains by links, Common Crawl
Hacker News stories
1
best: 1 points
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | May 2025 | $25M | Obvious Ventures lead, Lux Capital | Pulse 2.0 |
| Venture round | Dec 2023 | $4.3M | Andreessen Ho lead | Pulse 2.0 |
Registers and programsofficial lists and records that name the company
| Legal entity | Inductive Bio, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Benjamin BirnbaumExecutive Officer, DirectorSEC Form D
Joshua HaimsonExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one

backs PostEra

backs Genesis Molecular AI
Similar startupsby what they do, their industry and backers

A Turing test for pharmaceutical artificial intelligence adding medicinal chemists into discriminators in GANs.

Inceptive is a company founded in 2021 by a co-author of the transformer paper to design RNA molecules with deep learning. It treats…

InterAx Biotech integrates experimental and computational pharmacology to reveal critical properties of novel GPCR drug candidates. Work…

Axiom provides frontier intelligence for human drug toxicity, helping scientists reduce unexpected toxicity earlier and develop safer…

deepmirror is an AI-native drug design platform built around curated, non-public experimental molecule property measurements such as…

Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
Overview
Inductive Bio builds machine learning models that predict the absorption, distribution, metabolism and toxicity properties of drug candidates. Founded in 2021 in New York, it pools proprietary experimental data across partners to train models no single company could build alone. Medicinal chemists use the predictions to prioritise which molecules to synthesise.
News
Inductive Bio launches Indy, an AI chemistry assistant, to double the capacity of every medicinal chemist
/PRNewswire/ -- Inductive Bio today launched Indy, an AI chemistry assistant, available to partners now. Inductive
Read more
Report
Inductive Bio launches Indy, an AI chemistry assistant, to double the capacity of every medicinal chemist
Read more
Report
Inductive Bio Wins 3rd Consecutive AI Drug Discovery Benchmark
/PRNewswire/ -- Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, placed first in OpenADMET
Read more
Report
Inductive Bio joins Anthropic
Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, today announced that it has joined Anthropic
Read more
Report
Inductive Bio joins Anthropic's Connector Ecosystem for Life Sciences, Surfacing State-of-the-Art ADMET Prediction to Drug Discovery Scientists through Claude
Read more
Report
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
Ginkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching ADME-One, a fully integrated ADME platform for drug discovery teams co-developed with Tangible Scientific and Inductive Bio. ADME-One delivers a high-throughput Tier 1 A
Read more
Report
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
Read more
Report
Inductive Bio Announces an Up To $21M Award to Develop AI Drug Toxicity Models that Improve Drug Safety Assessment with Leading Academic and Biopharmaceutical Organizations
Inductive Bio, an AI drug discovery partner developing virtual chemistry labs, announced today that it has received an up to $21M award to lead a project to develop next-generation models of drug toxicity to advance safer therapeutics and reduce reliance
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Inductive Bio over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
4
Stack modernity
79/100
Languages
Python
Frameworks & libraries
JAX
PyTorch
TensorFlow
Practices & domains
AI Agents
Machine Learning
Reinforcement Learning
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$250k
Typical range
$230k – $275k
Open positions
6
4
Jobs
Staff
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Staff | 4 | $245k | $230k – $275k |
Highest paying role
Partnerships Lead
$275k
Normalized to USD per year
All salaries at Inductive Bio
By role, level and city, against the market · 6 jobs with pay
People

Benjamin Birnbaum
Executive Officer, Director

Joshua Haimson
Executive Officer, Director

Rohan Ganesh
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
51/100
Stable
Open positions
6
0 opened / 0 closed in 30 days
Median time-to-fill
234 days
faster than 7% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
AI/ML
40% ▲
Science & Research
40% ▲
Sales
20% ▼
Activity Timeline
Added Reinforcement Learning to stack
Sep 2026
Added JAX to stack
Sep 2026
Added Machine Learning to stack
Sep 2026
Added TensorFlow to stack
Sep 2026
Added Scikit-learn to stack
Sep 2026
Added PyTorch to stack
Sep 2026
Added Python to stack
Sep 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
1
Busiest office
New York
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
New York
United States
HQ
5 open roles 4 posted in 90 days 80% engineering 50-200 est. staff $249k Avg Salary
hires for AI/ML, Sales, Science & Research
Boston
United States
1 open roles 1 posted in 90 days 100% engineering 10-50 est. staff $250k Avg Salary
hires for Science & Research
Jobs
$180k – $250k per year • Hybrid • Full-Time • 4+ years exp • PhD • New York
Python
Reinforcement Learning
JAX
TensorFlow
PyTorch
Machine Learning
Apply
$180k – $230k per year • Hybrid • Full-Time • New York
Python
AI Agents
Apply
$180k – $240k per year • Hybrid • Full-Time • 4+ years exp • New York
AI Agents
Apply

Andreessen Horowitz
AlleyCorp
Lux Capital 


